913: Is there an efficacy tradeoff when reducing apixaban dose in patients with end-stage renal disease?
Released Monday, 15th April 2024
Good episode? Give it some love!
913: Is there an efficacy tradeoff when reducing apixaban dose in patients with end-stage renal disease?
913: Is there an efficacy tradeoff when reducing apixaban dose in patients with end-stage renal disease?
Monday, 15th April 2024
Good episode? Give it some love!
Rate Episode
Show notes at pharmacyjoe.com/episode913. In this episode, I’ll discuss the efficacy tradeoff when reducing apixaban dose in patients with end-stage renal disease.The post 913: Is there an efficacy tradeoff when reducing apixaban dose in patients with end-stage renal disease? appeared first on Pharmacy Joe.
Show More
Rate
From The Podcast
The Elective Rotation: A Critical Care Hospital Pharmacy Podcast
The Elective Rotation - the number 1 ranked Hospital Pharmacy podcast - is created for YOU Pharmacy Nation! If you are a Pharmacy Student, Resident, Pharmacist, Nurse, Physician, or Critical Care Practitioner in a hospital, intensive care unit (ICU) or emergency department looking to improve your practice, The Elective Rotation delivers unbiased critical care and hospital pharmacy content from a Board Certified Pharmacotherapy Specialist. Episodes are published every Monday and Thursday at 3AM EST. Find the show notes at pharmacyjoe.com.Join Podchaser to...
- Rate podcasts and episodes
- Follow podcasts and creators
- Create podcast and episode lists
- & much more
Episode Tags
Do you host or manage this podcast?
Claim and edit this page to your liking.
,Claim and edit this page to your liking.
Unlock more with Podchaser Pro
- Audience Insights
- Contact Information
- Demographics
- Charts
- Sponsor History
- and More!
- Account
- Register
- Log In
- Find Friends
- Resources
- Help Center
- Blog
- API
Podchaser is the ultimate destination for podcast data, search, and discovery. Learn More
- © 2024 Podchaser, Inc.
- Privacy Policy
- Terms of Service
- Contact Us